BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 28868764)

  • 1. The role of increased glucose on neurovascular dysfunction in patients with the metabolic syndrome.
    Rodrigues S; Cepeda FX; Toschi-Dias E; Dutra-Marques ACB; Carvalho JC; Costa-Hong V; Alves MJNN; Rondon MUPB; Bortolotto LA; Trombetta IC
    J Clin Hypertens (Greenwich); 2017 Sep; 19(9):840-847. PubMed ID: 28868764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic syndrome, glucose tolerance categories and the cardiovascular risk in Spanish population.
    Martínez-Larrad MT; Corbatón-Anchuelo A; Fernández-Pérez C; Lazcano-Redondo Y; Escobar-Jiménez F; Serrano-Ríos M
    Diabetes Res Clin Pract; 2016 Apr; 114():23-31. PubMed ID: 27103365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The association between pulse wave velocity and metabolic syndrome and adiponectin in patients with impaired fasting glucose: cardiovascular risks and adiponectin in IFG.
    Nam JS; Park JS; Cho MH; Jee SH; Lee HS; Ahn CW; Lowe WL; Kim KR
    Diabetes Res Clin Pract; 2009 May; 84(2):145-51. PubMed ID: 19261346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk and population attributable fraction of metabolic syndrome and impaired fasting glucose for the incidence of type 2 diabetes mellitus among middle-aged Japanese individuals: Aichi Worker's Cohort Study.
    Kaneko K; Yatsuya H; Li Y; Uemura M; Chiang C; Hirakawa Y; Ota A; Tamakoshi K; Aoyama A
    J Diabetes Investig; 2020 Sep; 11(5):1163-1169. PubMed ID: 32022993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroadrenergic dysfunction along the diabetes continuum: a comparative study in obese metabolic syndrome subjects.
    Straznicky NE; Grima MT; Sari CI; Eikelis N; Lambert EA; Nestel PJ; Esler MD; Dixon JB; Chopra R; Tilbrook AJ; Schlaich MP; Lambert GW
    Diabetes; 2012 Oct; 61(10):2506-16. PubMed ID: 22664956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is metabolic syndrome a condition independent of prediabetes and type 2 diabetes mellitus? A report from Turkey.
    Uzunlulu M; Oguz A
    Endocr J; 2007 Dec; 54(5):745-50. PubMed ID: 17878610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of ADMA, endothelial progenitor cells and traditional cardiovascular risk factors on pulse wave velocity among prediabetic individuals.
    Protopsaltis I; Foussas S; Angelidi A; Gritzapis A; Sergentanis TΝ; Matsagos S; Tzirogiannis K; Panoutsopoulos GI; Dimitriadis G; Raptis S; Melidonis A
    Cardiovasc Diabetol; 2012 Nov; 11():141. PubMed ID: 23153108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increasing derangement of glucose homeostasis is associated with increased arterial stiffness in patients with diabetes, impaired fasting glucose and normal controls.
    Lukich E; Matas Z; Boaz M; Shargorodsky M
    Diabetes Metab Res Rev; 2010 Jul; 26(5):365-70. PubMed ID: 20568265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired Fasting Glucose Is the Major Determinant of the 20-Year Mortality Risk Associated With Metabolic Syndrome in Nondiabetic Patients With Stable Coronary Artery Disease.
    Younis A; Goldkorn R; Goldenberg I; Geva D; Tzur B; Mazu A; Younis A; Fisman Z; Tannenbaum A; Klempfner R
    J Am Heart Assoc; 2017 Oct; 6(11):. PubMed ID: 29079562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of multielectrode renal denervation on elevated sympathetic nerve activity and insulin resistance in metabolic syndrome.
    Tsioufis C; Dimitriadis K; Kasiakogias A; Kalos T; Liatakis I; Koutra E; Nikolopoulou L; Kordalis A; Ella RO; Lau EO; Grassi G; Papademetriou V; Tousoulis D
    J Hypertens; 2017 May; 35(5):1100-1108. PubMed ID: 28106665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic syndrome may be associated with increased arterial stiffness even in the absence of hypertension: a study in 84 cases and 82 controls.
    Kangas P; Tikkakoski AJ; Tahvanainen AM; Leskinen MH; Viitala JM; Kähönen M; Kööbi T; Niemelä OJ; Mustonen JT; Pörsti IH
    Metabolism; 2013 Aug; 62(8):1114-22. PubMed ID: 23557592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evolution of target organ damage and haemodynamic parameters over 4 years in patients with increased insulin resistance: the LOD-DIABETES prospective observational study.
    Gómez-Marcos MÁ; Recio-Rodríguez JI; Patino-Alonso MC; Agudo-Conde C; Rodríguez-Sanchez E; Maderuelo-Fernandez JA; Gómez-Sánchez L; Gomez-Sanchez M; García-Ortiz L;
    BMJ Open; 2016 Jun; 6(6):e010400. PubMed ID: 27251684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of incident hypertension and arterial stiffness using the non-insulin-based metabolic score for insulin resistance (METS-IR) index.
    Bello-Chavolla OY; Antonio-Villa NE; Vargas-Vázquez A; Martagón AJ; Mehta R; Arellano-Campos O; Gómez-Velasco DV; Almeda-Valdés P; Cruz-Bautista I; Melgarejo-Hernandez MA; Muñoz-Hernandez L; Guillén LE; Garduño-García JJ; Alvirde U; Ono-Yoshikawa Y; Choza-Romero R; Sauque-Reyna L; Garay-Sevilla ME; Malacara-Hernandez JM; Tusié-Luna MT; Gutierrez-Robledo LM; Gómez-Pérez FJ; Rojas R; Aguilar-Salinas CA
    J Clin Hypertens (Greenwich); 2019 Aug; 21(8):1063-1070. PubMed ID: 31318156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased burden and severity of metabolic syndrome and arterial stiffness in treatment-naïve HIV+ patients from Cameroon.
    Ngatchou W; Lemogoum D; Ndobo P; Yagnigni E; Tiogou E; Nga E; Kouanfack C; van de Borne P; Hermans MP
    Vasc Health Risk Manag; 2013; 9():509-16. PubMed ID: 24043942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin resistance and the metabolic syndrome are associated with arterial stiffness in patients with chronic kidney disease.
    Chan DT; Watts GF; Irish AB; Ooi EM; Dogra GK
    Am J Hypertens; 2013 Sep; 26(9):1155-61. PubMed ID: 23736110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time delay of baroreflex control and oscillatory pattern of sympathetic activity in patients with metabolic syndrome and obstructive sleep apnea.
    Toschi-Dias E; Trombetta IC; Dias da Silva VJ; Maki-Nunes C; Cepeda FX; Alves MJ; Drager LF; Lorenzi-Filho G; Negrao CE; Rondon MU
    Am J Physiol Heart Circ Physiol; 2013 Apr; 304(7):H1038-44. PubMed ID: 23355343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for autonomic and somatic nerve dysfunction in different stages of glucose tolerance.
    Dimova R; Tankova T; Guergueltcheva V; Tournev I; Chakarova N; Grozeva G; Dakovska L
    J Diabetes Complications; 2017 Mar; 31(3):537-543. PubMed ID: 27894750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-high-density-lipoprotein cholesterol and cardiovascular risk factors among adolescents with and without impaired fasting glucose.
    Liu J; Joshi D; Sempos CT
    Appl Physiol Nutr Metab; 2009 Apr; 34(2):136-42. PubMed ID: 19370043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A recent history of preeclampsia is associated with elevated central pulse wave velocity and muscle sympathetic outflow.
    Usselman CW; Adler TE; Coovadia Y; Leone C; Paidas MJ; Stachenfeld NS
    Am J Physiol Heart Circ Physiol; 2020 Mar; 318(3):H581-H589. PubMed ID: 32004082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of traits of metabolic syndrome with glucose abnormalities.
    Hoffmann IS; Cubeddu LX
    Am J Ther; 2013; 20(4):363-8. PubMed ID: 23591026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.